QuidelOrtho
QDEL
#4896
Rank
ยฃ1.28 B
Marketcap
ยฃ19.05
Share price
-2.49%
Change (1 day)
-37.18%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.

Operating Margin for QuidelOrtho (QDEL)

Operating Margin as of July 2025 (TTM): -12.34%

According to QuidelOrtho's latest financial reports and stock price the company's current Operating Margin is -12.34%. At the end of 2024 the company had an Operating Margin of -76.59%.

Operating Margin history for QuidelOrtho from 2001 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
2024-76.59%7790.37%
2023-0.97%-104.31%
202222.53%-57.49%
202153.00%-15.34%
202062.61%333.9%
201914.43%18.89%
201812.14%-519.45%
2017-2.89%-65.78%
2016-8.45%78.35%
2015-4.74%-20.52%
2014-5.96%-407.96%
20131.94%-60.37%
20124.89%-32.51%
20117.24%-147.11%
2010-15.37%-148.42%
200931.74%36.63%
200823.23%33.65%
200717.38%22.62%
200614.18%-345.64%
2005-5.77%-386.72%
20042.01%-85.7%
200314.08%85.09%
20027.61%76.38%
20014.31%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Meridian Bioscience
VIVO
16.31%-232.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
8.06%-165.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
16.47%-233.47%๐Ÿ‡บ๐Ÿ‡ธ USA
OraSure Technologies
OSUR
-17.55% 42.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
19.45%-257.62%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
14.13%-214.51%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.